The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

Arista Networks ( ANET 2.64%) slumped 11% in pre-market trading, even though earnings per share rose 25% after the company ...

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...

Novo Nordisk once dominated the weight-loss drug market with Wegovy. However, rising competition, particularly from Eli Lilly ...

Trump called the case "literally, LIFE OR DEATH, for our Country" in a Truth Social post on Tuesday and arguments begin at 10 a.m. ET. Meanwhile Invesco said that, underscoring market confidence in ...

Pedersen, Maggie Fick and Bhanvi Satija COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year profit and ...

Discover why Hims & Hers Health (HIMS) remains a strong long-term buy after robust Q3 growth, new offerings, and expansion ...

COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk lowered its full-year profit and sales forecasts again on Wednesday, in an ...

Denmark's Novo Nordisk, the maker of Ozempic and Wegovy obesity drugs, said on Wednesday it was lowering its 2025 outlook for the third time this year, after posting tepid third-quarter results.

Another quarterly earnings announcement from Novo Nordisk and another downgrade to earnings guidance from the Danish ...